Education
About Us
Working with TipRanks
Follow Us
CBD Life Sciences (CBDL)
OTHER OTC:CBDL
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 98.32K | $ 108.89K | $ 167.15K | $ 160.24K | $ 59.26K |
| Gross Profit | $ 41.49K | $ -9.89K | $ -30.60K | $ -280.26K | $ -148.25K |
| Operating Income | $ -101.70K | $ -757.19K | $ -78.57K | $ -859.80K | $ -5.13M |
| EBITDA | $ -101.70K | $ -701.63K | $ -23.02K | $ -806.25K | $ -4.89M |
| Net Income | $ -48.93K | $ -757.19K | $ -78.57K | $ -859.80K | $ -5.13M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 331.60K | $ 6.55K | $ 2.52K | $ 558.00 | $ 1.03M |
| Total Assets | $ 805.23K | $ 406.75K | $ 419.33K | $ 473.16K | $ 1.36M |
| Total Debt | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Net Debt | $ -331.60K | $ -6.55K | $ -2.52K | $ -558.00 | $ -1.03M |
| Total Liabilities | $ 38.51K | $ 14.13K | $ 24.74K | $ 0.00 | $ 30.39K |
| Stockholders' Equity | $ 766.73K | $ 392.61K | $ 394.58K | $ 473.16K | $ 1.33M |
| Cash Flow | |||||
| Free Cash Flow | $ -139.15K | $ -583.08K | $ 1.96K | $ -1.03M | $ -5.31M |
| Operating Cash Flow | $ -139.15K | $ -583.08K | $ -16.64K | $ -957.32K | $ -5.15M |
| Investing Cash Flow | $ 47.17K | $ 0.00 | $ 0.00 | $ -69.00K | $ -161.55K |
| Financing Cash Flow | $ 143.50K | $ 587.11K | $ 18.60K | $ -153.14K | $ 6.72M |
CBD Life Sciences Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.